Review article · 2024 · Open access

Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging

Yoghalakshmi Nagarajan, Natarajan Chandrasekaran, Venkatachalam Deepa Parvathi

ChemistryOpen, 14(1), e202400232 · Published 21 October 2024 · DOI 10.1002/open.202400232

Open PDFView at the publisherCite this paper

In brief

“Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging” is a 2024 review article by Yoghalakshmi Nagarajan and 2 co-authors, published in ChemistryOpen. OpenAlex counts 8 citations as of 21 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at ChemistryOpen.

Citations
8
Most cited in
2025 (5)
Field-weighted impact
0.18
References
123
Authors
3

Abstract

Pancreatic cancer (PC) is one of the most fatal malignancies in the world. This lethality persists due to lack of effective and efficient treatment strategies. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive epithelial malignancy which has a high incidence rate and contributes to overall cancer fatalities. As of 2022, pancreatic cancer contributes to about 3 % of all cancers globally. Over the years, research has characterised germline predisposition, the origin cell, precursor lesions, genetic alterations, structural alterations, transcriptional changes, tumour heterogeneity, metastatic progression, and the tumour microenvironment, which has improved the understanding of PDAC carcinogenesis. By using molecular-based target therapies, these fundamental advancements support primary prevention, screening, early detection, and treatment. The focus of this review is the use of targeted nanoparticles as an alternative to conventional pancreatic cancer treatment due to the various side effects of the latter. The principles of nanoparticle based cancer therapy is efficient targeting of tumour cells via enhanced permeability and retention (EPR) effects and decrease the chemotherapy side effects due to their non-specificity. To increase the efficiency of existing therapies and modify target nanoparticles, several molecular markers of pancreatic cancer cells have been identified. Thus pancreatic cancer cells can be detected using appropriately functionalized nanoparticles with specific signalling molecules. Once cancer has been identified, these nanoparticles can kill the tumour by inducing hyperthermia, medication delivery, immunotherapy or gene therapy. As potent co-delivery methods for adjuvants and tumor-associated antigens; nanoparticles (NPs) have demonstrated significant promise as delivery vehicles in cancer therapy. This ensures the precise internalization of the functionalized nanoparticle and thus also activates the immune system effectively against tumor cells. This review also discusses the immunological factors behind the uptake of functionalized nanoparticles in cancer therapies. Theranostics, which combine imaging and therapeutic chemicals in a single nanocarrier, are the next generation of medicines. Pancreatic cancer treatment may be revolutionised by the development of a tailored nanocarrier with diagnostic, therapeutic, and imaging capabilities. It is extremely difficult to incorporate various therapeutic modalities into a single nanocarrier without compromising the individual functionalities. Surface modification of nanocarriers with antibodies or proteins will enable to attain multifunctionality which increases the efficiency of pancreatic cancer therapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nagarajan, Y., Chandrasekaran, N., & Parvathi, V. D. (2024). Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging. ChemistryOpen, 14(1), e202400232. https://doi.org/10.1002/open.202400232

MLA 9

Nagarajan, Yoghalakshmi, et al. “Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging.” ChemistryOpen, vol. 14, no. 1, 2024, p. e202400232. https://doi.org/10.1002/open.202400232.

Chicago

Nagarajan, Yoghalakshmi, Natarajan Chandrasekaran, and Venkatachalam Deepa Parvathi. 2024. “Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging.” ChemistryOpen 14 (1): e202400232. https://doi.org/10.1002/open.202400232.

Harvard

Nagarajan, Y., Chandrasekaran, N. and Parvathi, V. D. (2024) ‘Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging’, ChemistryOpen, 14(1), p. e202400232. doi:10.1002/open.202400232.

IEEE

Y. Nagarajan, N. Chandrasekaran, and V. D. Parvathi, “Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging,” ChemistryOpen, vol. 14, no. 1, p. e202400232, 2024, doi: 10.1002/open.202400232.

BibTeX

@article{nagarajan2024functionalized,
  title     = {{Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging}},
  author    = {Nagarajan, Yoghalakshmi and Chandrasekaran, Natarajan and Parvathi, Venkatachalam Deepa},
  journal   = {ChemistryOpen},
  year      = {2024},
  volume    = {14},
  number    = {1},
  pages     = {e202400232},
  doi       = {10.1002/open.202400232},
  url       = {https://doi.org/10.1002/open.202400232}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic cancer
  • pancreatic ductal adenocarcinoma
  • theranostics
  • functionalized nanoparticles
  • molecular imaging
  • targeted drug delivery
  • enhanced permeability and retention effect
  • hyperthermia

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Nagarajan, Y., Chandrasekaran, N., & Parvathi, V. D. (2024). Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging. ChemistryOpen, 14(1), e202400232. https://doi.org/10.1002/open.202400232

How many times has this paper been cited?

8 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at ChemistryOpen: sign in and open the PDF from this page.

Who wrote this paper?

Yoghalakshmi Nagarajan, Natarajan Chandrasekaran, Venkatachalam Deepa Parvathi.

What is the DOI of this paper?

10.1002/open.202400232, permanently at https://doi.org/10.1002/open.202400232. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.